EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Current Knowledge on the Pathophysiology of Tuberculosis and Potential of Inhaled Bacteriophage Therapy Against Tuberculosis

Yu Lin, Yifan Long, Hak-Kim Chan, Mary Garvey

Microorganisms · 16.11.2026 · 14 (11) · 2652

DOI: 10.3390/microorganisms14112652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 16.11.2026. Verfasst von Yu Lin und 3 weiteren Autor:innen. Die Arbeit nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Medical and Pharmaceutical College.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis remains a major health burden around the world. With the emergence of multi-drug-resistant and extensively drug-resistant Mycobacterium tuberculosis, the need for alternative antimicrobial strategies has increased. Bacteriophages can specifically infect and lyse bacteria, thereby having the potential for the treatment of tuberculosis. Administration via pulmonary delivery may offer a means of concentrating viable bacteriophages at the infection site within the deep lung while reducing systemic exposure. This review examines the pathophysiological and intracellular barriers relevant to pulmonary TB and evaluates current strategies for aerosolized phage delivery, including nebulization, dry-powder formulations, and macrophage-targeted delivery systems. Preclinical studies demonstrate promising aerosol performance, intracellular delivery, and antimycobacterial activity, particularly through engineered dry powders and liposomal systems; however, direct clinical evidence in pulmonary TB remains limited. Major challenges include maintaining phage viability during aerosol generation and storage, penetrating granulomatous lesions, and delivering sufficient active phages to intracellular M. tuberculosis within alveolar macrophages. Future translation will depend on improving phage stability during aerosolization, achieving efficient alveolar and intracellular delivery, overcoming host and lesion barriers, and establishing standardized manufacturing, safety, and regulatory frameworks.

Förderung

  • Chongqing Medical and Pharmaceutical College

Zitieren

APA

Lin, Y., Long, Y., Chan, H., & Garvey, M. (2026). Current Knowledge on the Pathophysiology of Tuberculosis and Potential of Inhaled Bacteriophage Therapy Against Tuberculosis. Microorganisms, 14(11), 2652. https://doi.org/10.3390/microorganisms14112652

Vancouver

Lin Y, Long Y, Chan H, Garvey M. Current Knowledge on the Pathophysiology of Tuberculosis and Potential of Inhaled Bacteriophage Therapy Against Tuberculosis. Microorganisms. 2026;14(11):2652. doi:10.3390/microorganisms14112652

BibTeX
@article{Lin2026,
  author = {Lin, Yu and Long, Yifan and Chan, Hak-Kim and Garvey, Mary},
  title = {Current Knowledge on the Pathophysiology of Tuberculosis and Potential of Inhaled Bacteriophage Therapy Against Tuberculosis},
  journal = {Microorganisms},
  year = {2026},
  volume = {14},
  number = {11},
  pages = {2652},
  doi = {10.3390/microorganisms14112652}
}
Kostenlos starten →